Search results
Showing 7171 to 7185 of 7707 results
Optical Coherence Tomography to guide percutaneous coronary intervention
In development [GID-IPG10394] Expected publication date: TBC
GID-MT557 Novii Wireless Patch System for maternal and fetal monitoring (MT509)
Discontinued [GID-MT557]
GID-MT563 NPi-200 for pupillary light reflex in critical care patients
Discontinued [GID-MT563]
In development [GID-TA11033] Expected publication date: TBC
The IN.PACT drug-coated balloon for peripheral arterial disease (CANCELLED)
Discontinued [GID-MT517]
Pemigatinib for treating myeloid or lymphoid neoplasms with a FGFR1 rearrangement [ID6172]
In development [GID-TA11109] Expected publication date: TBC
In development [GID-TA11252] Expected publication date: TBC
This medtech innovation briefing (MIB) has been replaced by NICE medical technologies guidance on Kurin Lock for blood culture collection.
Pirtobrutinib for treating relapsed or refractory mantle cell lymphoma [ID3975]
In development [GID-TA10858] Expected publication date: TBC
In development [GID-TA11199] Expected publication date: TBC
Parkinson's disease with motor fluctuations: safinamide (ES6)
This evidence summary has been updated and replaced by NICE guideline NG71.
Parkinson's disease with end-of-dose motor fluctuations: opicapone (ES9)
This evidence summary has been updated and replaced by NICE guideline NG71.
This evidence summary was produced at the start of the COVID-19 pandemic, when evidence was emerging. It has been withdrawn as the content is no longer relevant. See NICE's COVID-19 rapid guideline: managing COVID-19 for current guidance.
This evidence summary was produced at the start of the COVID-19 pandemic, when evidence was emerging. It has been withdrawn as the content is no longer relevant. See NICE's COVID-19 rapid guideline: managing COVID-19 for current guidance.
This evidence summary was produced at the start of the COVID-19 pandemic, when evidence was emerging. It has been withdrawn as the content is no longer relevant. See NICE's COVID-19 rapid guideline: managing COVID-19 for current guidance.